Jitka Vesela

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Prognostic Factors

Ejection Fraction

Top Venues

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Monika Kaisrlikova, David Kundrat, Pavla Koralkova, Iva Trsova, Zuzana Lenertova, Hana Votavova, Michaela Dostalova Merkerova, Zdenek Krejcik, Jitka Vesela, Martin Vostry, Radka Simeckova, Marketa Stastna Markova, Marie Lauermannova, Anna Jonášová, Jaroslav Cermak, Vladimír Divoký, Monika Belickova
Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower-risk myelodysplastic neoplasms. International journal of cancer 154 (9) (2024)
Monika Kaisrlikova, David Kundrat, Pavla Koralkova, Iva Trsova, Zuzana Lenertova, Hana Votavova, Michaela Dostalova Merkerova, Zdenek Krejcik, Jitka Vesela, Martin Vostry, Radka Simeckova, Marketa Stastna Markova, Marie Lauermannova, Anna Jonášová, Jaroslav Cermak, Vladimír Divoký, Monika Belickova
Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower-risk myelodysplastic neoplasms. International journal of cancer 154 (9) (2024)
Monika Kaisrlikova, David Kundrat, Pavla Koralkova, Iva Trsova, Zuzana Lenertova, Hana Votavova, Michaela Dostalova Merkerova, Zdenek Krejcik, Jitka Vesela, Martin Vostry, Radka Simeckova, Marketa Stastna Markova, Marie Lauermannova, Anna Jonášová, Jaroslav Cermak, Vladimír Divoký, Monika Belickova
Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower-risk myelodysplastic neoplasms. International journal of cancer (2024)
Monika Kaisrlikova, Jitka Vesela, David Kundrat, Hana Votavova, Michaela Dostalova Merkerova, Zdenek Krejcik, Vladimír Divoký, Marek Jedlicka, Jan Fric, Jiri Klema, Dana Mikulenkova, Marketa Stastna Markova, Marie Lauermannova, Jolana Mertova, Jacqueline Soukupova Maaloufova, Anna Jonášová, Jaroslav Cermak, Monika Belickova
RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS. Leukemia 36 (7) (2022)